US Large Caps in Focus - GILD+, CVS+ (22 January 2026)

Notes: we tend to focus on inflections on the weekly data level to strip out noise and, hopefully, call trades of more meaningful longevity. The basic system is a dynamic heatmap and colours: Up as Blue and Down as Red. Momentum is woven into the price series, such that paler colours represent lessening of power and stronger colours, increasing power. The sub-window shows the heatmap with momentum numbers at each timeframe from hourly to monthly.

Note: position change: we are closing SHORT, INTU US entered 13 January at 632.1 (see note of that day) cover at today's open. Gain at yesterday's close 17% (18.4% relative SPX). There might be more to go, but we are at the 11 April low and at the same oversold level as the start of the May 2022 rally - circa 25 RSI(9).

Gilead Sciences (GILD) - up-break.

The monthly heatmap row shows blue uptrend power incrementally building over the last five months and reaching comparable momentum levels to the previous solid blue uptrend phase (which ended nine months ago). The increase in power across the two blue sets points to a robust underpinned uptrend. Weekly has been in grey blue consolidation for seven weeks but has just broken through the top. This looks like a longer term uptrend re-join.

CVS Health Corp. (CVS) - intermediate term uptrend re-join.

This profile is not as strong as Gilead, but is essentially the same pattern. Strong uptrend blues, to consolidation, and price now testing the top of the range in a breakout.